Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)

CUSIP: 21833P301

Q1 2025 13F Holders as of 31 Mar 2025

Security identity
Security type / class
Equity / Common Stock, $0.0001 par value
Shares outstanding
17,685,185
Holder snapshot
Total 13F shares
10,430,351
Share change
-517,503
Total reported value
$55,391,632
Put/Call ratio
304%
Reported price per share
$5.31
Number of holders
85
Value change
-$13,394,437
Number of buys
38
Number of sells
51

Security key

21833P301

Report period

Q1 2025

Institutions

85

Top holders

10

CRBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 Corbus Pharmaceuticals Holdings, Inc. SEC filings Corbus Pharmaceuticals Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
ORBIMED ADVISORS LLC
13D/G signal
ORBIMED ADVISORS LLC
Evidence rows
15
Latest as of
31 Dec 2024
13F 13D/G Lead comparable stake: 5.9% 13D/G row: ORBIMED ADVISORS LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F 13D/G
Company · OrbiMed Capital LLC
13F 13D/G
5.9%
from 13D/G
$13,832,987
1,172,287 shares
 — 31 Dec 2024
Cormorant Asset Management, LP
13F
Company
13F
13%
$28,025,000
2,375,000 shares
 — 31 Dec 2024
Octagon Capital Advisors LP
13F
Company
13F
6.3%
$13,157,000
1,115,000 shares
 — 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
4.9%
$10,305,814
873,374 shares
 — 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
3.7%
$7,778,584
659,202 shares
 — 31 Dec 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
3%
$6,241,457
528,937 shares
 — 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
10,430,351
Rows available
85
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
98
Q1 2025 holders
85
Holder diff
-13
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .